ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research

By: Get News
CD BioSciences has recently announced the launch of label-free live cell imaging services for scientific studies.

New York, USA - December 26, 2022 - CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently announced the launch of label-free live cell imaging services for scientific studies, such as measuring the growth and proliferation of cells at the single-cell level and population level, and counting cells without cell staining.

Most biological research involves the study of cells. Whether viewed with the naked eye through a camera or a microscope, imaging live cells has become one of the most important parts of biological research. Meanwhile, fluorescence microscopy provides highly sensitive and specific imaging for living cells. Due to their small number of endogenous fluorescent molecules, fluorescent-labeled probes and antibodies can reveal the location of specific molecules in the cell. However, one of the major disadvantages of fluorescence imaging is that fluorescent labels on biological systems often pose challenges in observation and prediction for highly complex intracellular biological systems. Therefore, an ideal imaging tool for cell research should have high specificity and sensitivity while not requiring labeling.

Label-free live-cell imaging involves no exogenous reagents that may interfere with the physiological response under study, nor does it require treatment of cells with fixatives, which can be a cell-killing process. This imaging technique has been used by scientists to better understand cellular dynamics and biological function. CD BioSciences can provide comprehensive services based on label-free live cell imaging technologies.

Phase contrast (PC) and differential interference contrast (DIC) microscopy are the most popular label-free imaging techniques in biological research. Both techniques utilize specific optics to convert phase differences caused by cells and intracellular properties changes into light waves of various amplitudes. Unlike phase changes, changes in light waves can be detected by human eyes or recorded as pixel intensity changes on a camera. However, intensity in PC and DIC images is not a quantification of phase delay, and low image contrast can make automatic image segmentation difficult at high cell densities.

Quantitative phase imaging is label-free and provides higher content and contrast than conventional techniques. High-contrast images facilitate the generation of single-cell metrics through more robust segmentation and tracking, resulting in unlabeled dynamic phenotypes that describe cell-to-cell heterogeneity and temporal changes. Dynamic phenotypes at the single-cell level can better differentiate cells' response to treatment than population-level averages, which is clinically relevant, such as in cancer therapy. Furthermore, since the obtained data are unlabeled, the same set of cells can be used for further analysis or expansion, maximizing the potential benefits of regenerative and personalized medicine.

For customers interested in more information about label-free live cell imaging solutions or other technologies, please visit CD BioSciences at https://www.bioimagingtech.com.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms and interactions between protein molecules. In addition, the team is caple of applying powerful analytical software to capture images of cellular structure, subcellular, or tissues to obtain useful information.

Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email: Send Email
Phone: 1-315-636-4280
Country: United States
Website: https://www.bioimagingtech.com



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.